These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3290992)

  • 1. Apomorphine in the evaluation of dopaminergic function in man.
    Lal S
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):117-64. PubMed ID: 3290992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine: clinical studies on erectile impotence and yawning.
    Lal S; Tesfaye Y; Thavundayil JX; Thompson TR; Kiely ME; Nair NP; Grassino A; Dubrovsky B
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):329-39. PubMed ID: 2748870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tolerance of dopaminergic responses in man.
    Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
    Lal S; Ackman D; Thavundayil JX; Kiely ME; Etienne P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):695-9. PubMed ID: 6531440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for the study of yawning in man induced by the dopamine receptor agonist, apomorphine.
    Lal S; Grassino A; Thavundayil JX; Dubrovsky B
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):223-8. PubMed ID: 3628829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine-induced penile tumescence in impotent patients--preliminary findings.
    Lal S; Laryea E; Thavundayil JX; Nair NP; Negrete J; Ackman D; Blundell P; Gardiner RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):235-42. PubMed ID: 3628831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY; Lee MA; Jayathilake K
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of time-of-day on the yawning response to apomorphine in normal subjects.
    Lal S; Tesfaye Y; Thavundayil JX; Skorzewska A; Schwartz G
    Neuropsychobiology; 2000; 41(4):178-80. PubMed ID: 10828726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia.
    Duval F
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
    Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system.
    Laping NJ; Ramirez VD
    Pharmacol Biochem Behav; 1988 Jan; 29(1):59-62. PubMed ID: 3127835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary dopaminergic function in hepatic failure in man.
    Lal S; Oravec M; Aronoff A; Kiely ME; Guyda H; Solomon S; Nair NP
    J Neural Transm; 1982; 53(1):7-21. PubMed ID: 7062015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
    Dépatie L; Lal S
    J Psychiatry Neurosci; 2001 May; 26(3):203-20. PubMed ID: 11394190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methyltestosterone on the growth hormone response to the dopamine receptor agonist, apomorphine.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Guyda H; Ayotte C
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):263-8. PubMed ID: 1871327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.
    Mogilnicka E; Boissard CG; Delini-Stula A
    Neuropharmacology; 1984 Jan; 23(1):19-22. PubMed ID: 6144063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
    Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
    Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of drug-induced yawning and penile erections in rats.
    Gower AJ; Berendsen HH; Broekkamp CL
    Eur J Pharmacol; 1986 Mar; 122(2):239-44. PubMed ID: 2872065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.